Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
25.3.2021
0:00
17:39
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
Weitere Episoden von „JAMA Oncology Author Interviews“
Verpasse keine Episode von “JAMA Oncology Author Interviews” und abonniere ihn in der kostenlosen GetPodcast App.